Search
CY-1503
go.drugbank.com/drugs/DB17605InvestigationalCY-1503 is a pentasaccharide ethyl glycoside consisting of one alpha-D-sialylosyl residue as a sodium salt, two beta-D-galactopyranosyl residues, one 2-acetamido-beta-Dglucopyranosyl unit, and one alpha-L-fucopyranosyl
CP-39,332
go.drugbank.com/drugs/DB09193ExperimentalIt is part of a group of monoamine reuptake inhibitor stereoisomers including tametraline (1R,4S-), CP-24,442 (1S,4R-), CP-22,185 (cis-), and CP-22,186 that show varying efficiency.
Tidiacic arginine
go.drugbank.com/drugs/DB13748ExperimentalCategories: Bile and Liver Therapy, Alimentary Tract and MetabolismArpraziquantel
go.drugbank.com/drugs/DB11749Investigational(R)-Praziquantel is under investigation in clinical trial NCT02271984 (Relative Bioavailability Trial of L-Praziquantel in Healthy Volunteers).
Categories: Quinoline Derivatives and Related Substances, Antiparasitic Products, Insecticides and RepellentsPafuramidine
go.drugbank.com/drugs/DB06532InvestigationalPafuramidine, a prodrug of furamidine, currently has orphan status for Pneumocystis jiroveci pneumonia.
Aminoflavone
go.drugbank.com/drugs/DB19077InvestigationalAminoflavone is under investigation in clinical trial NCT01015521 (Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer).
Dexepicatechin
go.drugbank.com/drugs/DB19253InvestigationalDexepicatechin is under investigation in clinical trial NCT02964377 (Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents).
Asoprisnil
go.drugbank.com/drugs/DB06680InvestigationalIt can be used to treat progesterone sensitive myomata.
(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
go.drugbank.com/drugs/DB08553ExperimentalThis compound belongs to the phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.
Chiauranib
go.drugbank.com/drugs/DB16124InvestigationalChiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).